• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
IMCS

IMCS

A leader in recombinant enzymes and automated micro-chromatography technologies

  • ABOUT
    • ABOUT IMCS
    • QUALITY POLICY
    • RESEARCH AT IMCS
    • CAREERS
  • PRODUCTS
    • IMCSzyme®
      • IMCSzyme E1F
      • IMCSzyme RT
      • IMCSzyme® CATALOG
    • IMCStips®
      • APPLICATIONS
        • AFFINITY
        • SIZE EXCLUSION
        • NUCLEIC ACIDS
        • ION EXCHANGE
        • REVERSE PHASE
        • PHOSPHOPEPTIDE
      • IMCStips® CATALOG
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • SULFATASES
      • Sulfazyme
      • Sulfazyme™ DS
      • Sulfazyme™ β-AS
    • GLYCO REAGENTS
      • GLYCOLIPIDS
      • ACTIVATED SUGARS
      • BIOSYNTHETIC ENZYMES
      • SMALL MOLECULES
    • SPHINGOSINES
    • OTHER PROTEINS
      • PURIFIED STREPTAVIDIN
      • B. pi. β-glucuronidase variant
  • SERVICES
    • BETA-GLUCURONIDASES & SULFATASES
      • β-GLUCURONIDASE VALIDATION SERVICES
      • HIGH-THROUGHPUT TOXICOLOGY WORKFLOWS
    • IMCStips®
      • SAMPLE PREPARATION AUTOMATION
      • HIGH-THROUGHPUT METHOD DEVELOPMENT
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • OTHER SERVICES
      • GLYCAN PRODUCTION (Coming Soon)
      • R&D COLLABORATIONS
      • EXTRACELLULAR VESICLES
  • RESOURCES
    • FAQ
    • IMCSZYME RESOURCES
    • IMCSTIPS RESOURCES
    • SAFETY DATA SHEETS
    • CERTIFICATE OF ANALYSIS
  • LATEST NEWS
    • LATEST NEWS
    • PODCAST
    • BLOG
    • EVENTS
    • WEBINARS
  • SHOP
  • CONTACT
  • en
    • en
    • es
    • fr
    • de
    • zh-CN

Journal Article: Incorporation of Automated Buffer Exchange Empowers High-Throughput Protein and Plasmid Purification for Downstream Uses

March 7, 2023
Table of Contents
    Add a header to begin generating the table of contents

    INTRODUCTION

    As the biopharmaceutical industry continues to grow at a rapid pace, there is a greater need for high-throughput workflows to meet the demand for novel biotherapeutics. Automated liquid handlers (ALH) have gained popularity for sample preparation and purification, but the time-consuming off-deck buffer exchange step remains a bottleneck for many workflows.

    We have recently shown that SizeX IMCStips® enables rapid and automated buffer exchange of 96 mAb samples in as little as ten minutes, saving significant processing time for end users without adversely affecting sample product quality attributes (PQAs).[1][2] These findings have important implications for affinity purification and plasmid purification workflows, demonstrating the broad potential of this approach. As scientists seek to streamline their workflows and accelerate time-to-market for new products, automation technologies powered by IMCStips will undoubtedly play a critical role.

    Our latest publication in SLAS Technology highlights IMCS’s successful incorporation of automated buffer exchange into two fully automated workflows: affinity purification and anion exchange. By using pipet-based dispersive solid-phase extraction (dSPE), these workflows are highly adaptable and can address production constraints for biotherapeutics. The inclusion of buffer exchange as a last step in both workflows enables further integration for downstream processing, saving valuable time and increasing efficiency. These findings demonstrate the benefits of incorporating IMCStips into high-throughput protein and plasmid purification, paving the way for a more streamlined and effective biotherapeutics discovery process.

    METHODOLOGY

    The study utilized Ni-IMAC IMCStips for affinity purification and SizeX IMCStips for the automated protein purification workflow and µPure LE IMCStips with SizeX for the automated plasmid purification (or automated miniprep) workflow. The combined affinity and buffer exchange workflow was also used to test the effect of time post-induction on protein production. The methods were automated on a Hamilton Microlab STAR.

    TIPS_Pipettes_wResin_All_Steps_Image_V3

    The pipette-based dispersive solid-phase extraction (dSPE) approach optimizes sample binding to resin by utilizing repeated aspiration and dispensing cycles via an automated liquid handler (ALH).

    WORKFLOW

    slas automated workflow
    1. Biologic agent purification from cell lysate Expand
    2. IMCStips for affinity or IEX purification Expand

    Next is an affinity enrichment of poly-his tagged proteins from crude lysate.

    Protein size and load were related to the effectiveness of protein purification. The yield at the greatest protein load decreases as protein size increases. This is most likely due to the lowered diffusivity of the protein. Additionally, the decreased availability of binding sites due to steric bulk may have slowed the protein’s ability to bind to porous binding sites.

    The amount of protein that was still in solution was less than the difference between eluted protein and starting load. Protein remaining in the dead volume of the tip can be attributed to the extra-particle volume of the loose resin and the comparatively low six-column volume elution. An additional elution might be added to lessen the amount of protein retained if overall recovery is the most crucial factor.

    Depending on the end user’s objectives, the program’s flexibility allows for the number of cycles to be readily changed, either to reduce overall processing time or to bind more protein.

    3. Buffer exchange with SizeX IMCStips Expand

    After affinity purification, samples were buffer exchanged using SizeX150.

    SizeX tips operate in a manner like size-exclusion purification on a rapid protein liquid chromatography system: sample is loaded on top of a flat column bed, and positive pressure is employed to force the liquid through a packed bed. In this instance, the pressure is obtained from the STAR pipetting channel’s plunger movement. These plunger movements were optimized to balance recovery, volume, desalting effectiveness, and concentration.

    Although a greater chaser volume may be more forgiving when a smaller protein is used, the larger proteins in this study would pass through the SizeX150 more quickly, resulting in increased protein loss in the breakthrough fraction. Despite the greater volume’s higher overall recovery, 170 µL was chosen as the chaser dispense amount rather than 200 µL because of the diluting effect these conditions imposed. This is probably because the protein distribution widens as it moves through the column. The protein is more efficiently captured by a larger chaser, but the final product is diluted because the larger chaser catches the tail end of the distribution.

    These values can be changed, just like the affinity protocol. If maximizing product recovery overall is a priority, chaser dispensing settings can be adjusted to capture the entire protein load while still rejecting tiny compounds like imidazole. Remarkably, imidazole concentrations remained below the limit of detection even under the greatest elution volume settings.

    4. Eluate is ready for downstream processing Expand

    RESULTS

    Automated Protein Purification
    Combining the workflows for affinity and buffer exchange resulted in clean, usable protein in less than 80 minutes. Recovery rates were a little bit higher than the sum of the two separate phases. As anticipated, the pattern exhibited in distinct affinity purifications was reflected in the overall yield. Although the yields were 15–20% lower than with IMAC-only purification, exchange into the suitable buffer had already been carried out after the initial purification phase, offering numerous advantages over dialysis or spin-column. The combined chromatography methods of affinity purification and buffer exchange on automated liquid handlers can be used for high-throughput workflows.

    slas 1

    Affinity purification followed by buffer exchange on an automated liquid handler for high-throughput workflows. Polyhistidine-labeled proteins (GFP, ArSulf, βGlc) were added to bacterial lysates and purified using the Ni-IMAC method in a pipette format followed by SizeX150 desalting. Percent recoveries (A) and recovered amounts (B) correspond to the initial amount of protein added to the lysate. (C) SDS-PAGE of the proteins at different quantities correspond with NanoDrop and fluorescence measurements. (D) Enzyme activity assay using p-nitrocatechol sulfate (pNCS) indicates ArSulf remains active after undergoing the combined automated affinity and buffer exchange workflow. ArSulf converts pNCS into red, indicating enzyme activity. Yellow wells contain no ArSulf, demonstrating no well or tip carryover.[3]

    Automated Plasmid Purification
    The study demonstrated a new method for automated plasmid DNA purification (or automated miniprep purification) that results in low-endotoxin samples suitable for transfection and sequencing. Unlike many commonly used silica-based purification methods, this new method removes lipopolysaccharides that can trigger immune responses and reduce transfection effectiveness. The purified plasmid yields were sufficient for downstream use and similar for plasmids of different sizes. The inclusion of Triton X-114 in the purification process reduced endotoxin content. This method is suitable for up to 96 samples simultaneously and can purify ≥10 µg of low-endotoxin pDNA/sample in under 60 min, making it a fast and efficient alternative to other purification methods.

    slas 2

    The amount of plasmid recovered in µg varied based on the size of the plasmid construct. (A) Recoveries for pCRS158 were significantly higher than those for pCRS166 and pCRS240.3. (B) The final concentration of plasmid in the elution well varied by plasmid construct. The concentration of pCRS158 was significantly higher than that of either pCRS166 or pCRS240.3. (C) The volume eluted from the SizeX100 tip varied slightly by construct. The volume of the pCRS158 eluate was significantly lower than in pCRS240.3. *p<0.05; ns: not significant.[3]

    CONCLUSION

    One of the earliest and most common phases in biotherapeutic characterization and discovery is the purification of a biological agent. IMCS introduces the idea of tip-based buffer exchange using a zero-pressure pipet pick-up step and precise air displacement controls on the Hamilton Microlab STAR. Affinity enrichment and anion exchange chromatography were used with this approach to achieve downstream-ready protein and plasmid DNA purifications, respectively. By enabling researchers to prepare their purified product for following procedures without manual intervention, the development of an automated buffer exchange method contributes to the alleviation of a significant bottleneck in the production of biotherapeutics.

    REFERENCES

    1. Sitasuwan, P., Powers, T. W., Medwid, T., Huang, Y., Bare, B., & Lee, L. A. (2021). Enhancing the multi-attribute method through an automated and high-throughput sample preparation. MAbs, 13(1). https://doi.org/10.1080/19420862.2021.1978131
    2. Ogata, Y., Quizon, P. M., Nightlinger, N. S., Sitasuwan, P., Snodgrass, C., Lee, L. A., Meyer, J. D., & Rogers, R. S. (2022). Automated multi‐attribute method sample preparation using high‐throughput buffer exchange tips. Rapid Communications in Mass Spectrometry, 36(3), 1–10. https://doi.org/10.1002/rcm.9222
    3. P.A. Kates, J.N. Cook, R. Ghan et al., Incorporation of automated buffer exchange empowers high-throughput protein and plasmid purification for downstream uses, SLAS Technology, https://doi.org/10.1016/j.slast.2023.01.005

    Ready to automate with IMCStips? Contact us today for a free sample!

    Get Started
    Category: BLOG, LATEST NEWS
    Previous Post:Miniaturized Sample Preparation with IMCStips dSPE vs. Traditional Methods
    Next Post:A Quick Guide to PCR Cleanup: Comparing Traditional Techniques with Automated PCR Cleanup with IMCStips

    Customize Your Workflow

    IMCS recognizes our customers’ needs vary, which is why we provide tailored tools and services to help you reach your laboratory’s goals.

    VIEW OUR CUSTOM SOLUTIONS

    ABOUT IMCS

    INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC. (IMCS) IS A BIOTECHNOLOGY COMPANY FOCUSED ON DELIVERING TOOLS AND SERVICES THAT HELP PAVE THE WAY FOR THE FUTURE OF PRECISION MEDICINE. WE STRIVE TO ADDRESS THE GROWING NEEDS OF CLINICAL AND RESEARCH LABORATORIES THROUGH ADVANCED TECHNOLOGIES THAT INCREASE TESTING EFFICIENCY AND ACCURACY.

    STAY UP TO DATE

    WANT REGULAR UPDATES ON OUR INNOVATIVE PRODUCTS?
    Sign up to receive exclusive emails and offers from IMCS.
    !
    !
    !
    Subscribe
    Something went wrong. Please check your entries and try again.

    ABOUT

    ABOUT IMCS

    CAREERS

    QUALITY POLICY

    RESEARCH AT IMCS

    PRODUCTS

    IMCSZYME

    IMCSZYME RT

    IMCSTIPS

    PROTEINS, ENZYMES, RESINS

    GLYCO REAGENTS

    TERMS

    TERMS OF USE

    PRIVACY POLICY

    STANDARD TERMS AND CONDITIONS

    FCOI POLICY

    CONNECT WITH US

    IMCS, Inc. Headquarters
    110 Centrum Drive
    Irmo, SC 29063

    • IMCS LinkedIn Page
    • IMCS Facebook Page
    • IMCS Twitter Page

    COPYRIGHT © 2026 · IMCS · ALL RIGHTS RESERVED ·

    Return to top

    Get Started Today!

    Please fill out the form below to get started.

    "*" indicates required fields

    Step 1 of 3

    33%
    Which IMCStips applications you are interested in? Please select all that apply.*
    Name*
    Automated Liquid Handling System*
    Consent*

    Caleb-Schlachter-for-web

    Caleb R. Schlachter, Ph.D.

    Principal Scientist
    Caleb R. Schlachter, Ph.D., as the Principal Scientist at IMCS, leads and provides guidance for several research and development projects that involve proteins, including enzymes for glycan hydrolysis and glycan synthesis. He has co-authored multiple patents, posters, and peer-reviewed articles on β-glucuronidases and sulfatases.
    Gray Amick for web

    Gray D. Amick, Ph.D.

    Director of Operations
    Gray D. Amick, Ph.D., is the Director of Operations at IMCS with over 26 years of experience in forensic DNA analysis and toxicology. Prior to joining IMCS, he led forensic DNA testing for the Richland County Sheriff’s Department as technical leader and lab director. He has been court-qualified as an expert over 100 times and has authored and co-authored multiple posters and peer-reviewed articles.
    Amanda M Headshot

    Amanda C. McGee

    Research Scientist
    Amanda C. McGee is a Research Scientist at IMCS involved with enzyme characterizations, new analytical method developments, and advanced technical support. She joined IMCS with several years of experience in analytical testing for active pharmaceutical ingredients as per cGMP, USP and ICH guidelines. She has co-authored peer reviewed articles in the Journal of Analytical Toxicology and presented research at national and international conferences.
    Andrew_Headshot

    L. Andrew Lee, Ph.D.

    Co-Founder and Chief Scientific Officer
    L. Andrew Lee, Ph.D. co-founded IMCS and leads research and development efforts in enzyme engineering and automated micro-chromatography workflows. He directs new market efforts in glycan synthesis, supported by three NIH Fast-Track awards.

    Get started with 2N1 below

    "*" indicates required fields

    Name*
    Would you be interested in joining the 2N1 beta program?*
    Which product are you interested in? (select all that apply)*
    What are your current purification workflows? (select all that apply)*
    Please select your automation platform(s) (select all that apply)*
    How soon are you planning on evaluating 2N1?*
    Consent*

    DOWNLOAD OUR POSTERS

    "*" indicates required fields

    This field is for validation purposes and should be left unchanged.
    Please select the posters you would like to download*
    Name*
    Please provide a valid email so we can send you the download link.
    Location*
    Automated Liquid Handling System
    Contact preferences*
    Consent*

    Podcast Form

    "*" indicates required fields

    Name*
    How would you like to connect?*
    Please let us know what's on your mind. Have a question for us? Ask away.

    Ready for a change? Get your FREE sample of IMCSzyme® RT today.

    "*" indicates required fields

    This field is for validation purposes and should be left unchanged.
    Name*
    Consent*